Global Pharmacovigilance (PV) Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmacovigilance (PV) Revenue
• 1.4 Market by Type
  • 1.4.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Spontaneous Reporting
  • 1.4.3 Intensified ADR Reporting
  • 1.4.4 Targeted Spontaneous Reporting
  • 1.4.5 Cohort Event Monitoring
  • 1.4.6 EHR Mining
• 1.5 Market by Application
  • 1.5.1 Global Pharmacovigilance (PV) Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Research Organizations
  • 1.5.4 Industrial
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmacovigilance (PV) Market Perspective (2015-2026)
• 2.2 Global Pharmacovigilance (PV) Growth Trends by Regions
  • 2.2.1 Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmacovigilance (PV) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmacovigilance (PV) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmacovigilance (PV) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmacovigilance (PV) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmacovigilance (PV) Players by Market Size
  • 3.1.1 Global Top Pharmacovigilance (PV) Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmacovigilance (PV) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmacovigilance (PV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmacovigilance (PV) Market Concentration Ratio
  • 3.2.1 Global Pharmacovigilance (PV) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Revenue in 2019
• 3.3 Pharmacovigilance (PV) Key Players Head office and Area Served
• 3.4 Key Players Pharmacovigilance (PV) Product Solution and Service
• 3.5 Date of Enter into Pharmacovigilance (PV) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Pharmacovigilance (PV) Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmacovigilance (PV) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Pharmacovigilance (PV) Market Size by Application (2015-2020)
• 5.2 Global Pharmacovigilance (PV) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmacovigilance (PV) Market Size (2015-2020)
• 6.2 Pharmacovigilance (PV) Key Players in North America (2019-2020)
• 6.3 North America Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 6.4 North America Pharmacovigilance (PV) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmacovigilance (PV) Market Size (2015-2020)
• 7.2 Pharmacovigilance (PV) Key Players in Europe (2019-2020)
• 7.3 Europe Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 7.4 Europe Pharmacovigilance (PV) Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmacovigilance (PV) Market Size (2015-2020)
• 8.2 Pharmacovigilance (PV) Key Players in China (2019-2020)
• 8.3 China Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 8.4 China Pharmacovigilance (PV) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmacovigilance (PV) Market Size (2015-2020)
• 9.2 Pharmacovigilance (PV) Key Players in Japan (2019-2020)
• 9.3 Japan Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 9.4 Japan Pharmacovigilance (PV) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmacovigilance (PV) Market Size (2015-2020)
• 10.2 Pharmacovigilance (PV) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmacovigilance (PV) Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmacovigilance (PV) Market Size (2015-2020)
• 11.2 Pharmacovigilance (PV) Key Players in India (2019-2020)
• 11.3 India Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 11.4 India Pharmacovigilance (PV) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmacovigilance (PV) Market Size (2015-2020)
• 12.2 Pharmacovigilance (PV) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmacovigilance (PV) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Accenture
  • 13.1.1 Accenture Company Details
  • 13.1.2 Accenture Business Overview
  • 13.1.3 Accenture Pharmacovigilance (PV) Introduction
  • 13.1.4 Accenture Revenue in Pharmacovigilance (PV) Business (2015-2020))
  • 13.1.5 Accenture Recent Development
• 13.2 Clinquest Group B.V.
  • 13.2.1 Clinquest Group B.V. Company Details
  • 13.2.2 Clinquest Group B.V. Business Overview
  • 13.2.3 Clinquest Group B.V. Pharmacovigilance (PV) Introduction
  • 13.2.4 Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.2.5 Clinquest Group B.V. Recent Development
• 13.3 Cognizant
  • 13.3.1 Cognizant Company Details
  • 13.3.2 Cognizant Business Overview
  • 13.3.3 Cognizant Pharmacovigilance (PV) Introduction
  • 13.3.4 Cognizant Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.3.5 Cognizant Recent Development
• 13.4 Laboratory Corporation of America Holdings
  • 13.4.1 Laboratory Corporation of America Holdings Company Details
  • 13.4.2 Laboratory Corporation of America Holdings Business Overview
  • 13.4.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Introduction
  • 13.4.4 Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.4.5 Laboratory Corporation of America Holdings Recent Development
• 13.5 IBM Corporation
  • 13.5.1 IBM Corporation Company Details
  • 13.5.2 IBM Corporation Business Overview
  • 13.5.3 IBM Corporation Pharmacovigilance (PV) Introduction
  • 13.5.4 IBM Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.5.5 IBM Corporation Recent Development
• 13.6 ArisGlobal
  • 13.6.1 ArisGlobal Company Details
  • 13.6.2 ArisGlobal Business Overview
  • 13.6.3 ArisGlobal Pharmacovigilance (PV) Introduction
  • 13.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.6.5 ArisGlobal Recent Development
• 13.7 ICON plc.
  • 13.7.1 ICON plc. Company Details
  • 13.7.2 ICON plc. Business Overview
  • 13.7.3 ICON plc. Pharmacovigilance (PV) Introduction
  • 13.7.4 ICON plc. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.7.5 ICON plc. Recent Development
• 13.8 Capgemini
  • 13.8.1 Capgemini Company Details
  • 13.8.2 Capgemini Business Overview
  • 13.8.3 Capgemini Pharmacovigilance (PV) Introduction
  • 13.8.4 Capgemini Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.8.5 Capgemini Recent Development
• 13.9 ITClinical
  • 13.9.1 ITClinical Company Details
  • 13.9.2 ITClinical Business Overview
  • 13.9.3 ITClinical Pharmacovigilance (PV) Introduction
  • 13.9.4 ITClinical Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.9.5 ITClinical Recent Development
• 13.10 iMEDGlobal
  • 13.10.1 iMEDGlobal Company Details
  • 13.10.2 iMEDGlobal Business Overview
  • 13.10.3 iMEDGlobal Pharmacovigilance (PV) Introduction
  • 13.10.4 iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 13.10.5 iMEDGlobal Recent Development
• 13.11 Foresight Group International AG
  • 10.11.1 Foresight Group International AG Company Details
  • 10.11.2 Foresight Group International AG Business Overview
  • 10.11.3 Foresight Group International AG Pharmacovigilance (PV) Introduction
  • 10.11.4 Foresight Group International AG Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.11.5 Foresight Group International AG Recent Development
• 13.12 TAKE Solutions Ltd.
  • 10.12.1 TAKE Solutions Ltd. Company Details
  • 10.12.2 TAKE Solutions Ltd. Business Overview
  • 10.12.3 TAKE Solutions Ltd. Pharmacovigilance (PV) Introduction
  • 10.12.4 TAKE Solutions Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.12.5 TAKE Solutions Ltd. Recent Development
• 13.13 PAREXEL International Corporation
  • 10.13.1 PAREXEL International Corporation Company Details
  • 10.13.2 PAREXEL International Corporation Business Overview
  • 10.13.3 PAREXEL International Corporation Pharmacovigilance (PV) Introduction
  • 10.13.4 PAREXEL International Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.13.5 PAREXEL International Corporation Recent Development
• 13.14 BioClinica
  • 10.14.1 BioClinica Company Details
  • 10.14.2 BioClinica Business Overview
  • 10.14.3 BioClinica Pharmacovigilance (PV) Introduction
  • 10.14.4 BioClinica Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.14.5 BioClinica Recent Development
• 13.15 Wipro Ltd.
  • 10.15.1 Wipro Ltd. Company Details
  • 10.15.2 Wipro Ltd. Business Overview
  • 10.15.3 Wipro Ltd. Pharmacovigilance (PV) Introduction
  • 10.15.4 Wipro Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.15.5 Wipro Ltd. Recent Development
• 13.16 United BioSource Corporation
  • 10.16.1 United BioSource Corporation Company Details
  • 10.16.2 United BioSource Corporation Business Overview
  • 10.16.3 United BioSource Corporation Pharmacovigilance (PV) Introduction
  • 10.16.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.16.5 United BioSource Corporation Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer